Zevra Therapeutics (ZVRA) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for Zevra Therapeutics (ZVRA) over the last 10 years, with Q3 2025 value amounting to -$1.7 million.
- Zevra Therapeutics' Other Gross PP&E Adjustments rose 7741.8% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year increase of 7741.8%. This contributed to the annual value of -$4.7 million for FY2024, which is 2214.94% down from last year.
- Per Zevra Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$1.7 million for Q3 2025, which was up 7741.8% from -$2.1 million recorded in Q2 2025.
- Zevra Therapeutics' 5-year Other Gross PP&E Adjustments high stood at -$698000.0 for Q3 2023, and its period low was -$7.3 million during Q3 2024.
- For the 5-year period, Zevra Therapeutics' Other Gross PP&E Adjustments averaged around -$3.0 million, with its median value being -$1.7 million (2025).
- Per our database at Business Quant, Zevra Therapeutics' Other Gross PP&E Adjustments tumbled by 94871.06% in 2024 and then skyrocketed by 7741.8% in 2025.
- Zevra Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$3.1 million in 2021, then rose by 6.47% to -$2.9 million in 2022, then fell by 29.94% to -$3.8 million in 2023, then dropped by 22.15% to -$4.7 million in 2024, then soared by 64.53% to -$1.7 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$1.7 million for Q3 2025, versus -$2.1 million for Q2 2025 and -$6.5 million for Q1 2025.